Shinobi strikes deal with electronics powerhouse Panasonic to create new cell therapy manufacturing platform
Fierce Pharma
APRIL 18, 2024
History is coming full circle as induced pluripotent stem (iPS) cell-derived cell therapy maker Shinobi Therapeutics links up with Panasonic and Japan’s Kyoto University, where the first mouse iPS | Shinobi Therapeutics has entered an accord with electronics powerhouse Panasonic and Kyoto University in a bid to develop a new closed-system manufacturing (..)
Let's personalize your content